Work

Ab0759 Four-year Efficacy and Safety of Guselkumab in Psoriasis Patients With and Without Psoriatic Arthritis: a Pooled Analysis From Voyage 1 and Voyage 2

Year: 2020

Type: conference-abstract

Source: Annals of the Rheumatic Diseases

DOI: 10.1136/annrheumdis-2020-eular.1333

Authors: K. Reich, J. Dutz, P. Foley, D. Thaçi, R. Vender, M. Song, M. Miller, Y. You, S. Li, Y.K. Shen, A. Armstrong

Institutions: University Medical Center Hamburg-Eppendorf, Vancouver General Hospital, St Vincent's Hospital Melbourne, Skin and Cancer Foundation, University of Lübeck, McMaster University, Janssen Research & Development (United States), Janssen Scientific Affairs (United States), University of Southern California

Language: English

Topic: Psoriasis: Treatment and Pathogenesis

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W3035007198

Cites:

Cited by: 1

Related to: 10